A retrospective study to evaluate antifungal prophylaxis regimens in patients with acute myeloid leukemia receiving induction chemotherapy

Trial Profile

A retrospective study to evaluate antifungal prophylaxis regimens in patients with acute myeloid leukemia receiving induction chemotherapy

Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Oct 2015

At a glance

  • Drugs Micafungin (Primary) ; Posaconazole (Primary)
  • Indications Mycoses
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Oct 2015 New trial record
    • 14 Sep 2015 Results published in Joint 55th Interscience Conference on Antimicrobial Agents and Chemotherapy and 28th International Congress of Chemotherapy
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top